MOUNTAIN VIEW, Calif., May 8, 2014 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, announced today its financial results for the first quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
